Fundraising Fox株式会社リボルナバイオサイエンス
Fujisawa, JP · 2 known investors
Find your way into 株式会社リボルナバイオサイエンス
Sign up to see every warm intro you have to 株式会社リボルナバイオサイエンス
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 株式会社リボルナバイオサイエンス team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Reborna Biosciences is a Japanese biotech company that researches and develops RNA-targeting small-molecule drugs for hereditary rare diseases. Founded in 2018, it operates from the Shonan iPark research campus.
Founders & leadership
KF
Koji FujiRepresentative Director
YO
Yukimi OdaDirector, CFO
Investors · 2
Frequently asked questions
- What does 株式会社リボルナバイオサイエンス do?
- Reborna Biosciences is a Japanese biotech company that researches and develops RNA-targeting small-molecule drugs for hereditary rare diseases. Founded in 2018, it operates from the Shonan iPark research campus.
- Who are 株式会社リボルナバイオサイエンス's investors?
- 株式会社リボルナバイオサイエンス's investors include Angel Bridge Co.,Ltd., UntroD Capital.
- Where is 株式会社リボルナバイオサイエンス headquartered?
- 株式会社リボルナバイオサイエンス is headquartered in Fujisawa, JP.